Impact of Novel Thoracic Wall Blocks With Dexmetomidine on Inflammatory Markers Following Breast Cancer Surgery

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The study will test the hypothesis that inflammatory markers measured at 24 hours after breast cancer surgery will be lower in patients receiving PECS II and PIFB blocks, supplemented with dexmetomidine compared to standard care group.
Epistemonikos ID: 5c8ceb634d28e261081c51bb1ca6033fac86149b
First added on: Jul 21, 2023